Released: ·Last reviewed: ·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Kim Callender, NP (FNP-BC)
Medical Reviewer · Nurse Practitioner (FNP-BC)
Kim Callender, NP (FNP-BC) is a family nurse practitioner and one of the two medical reviewers named on every Transparent Peptide page, alongside Dr. Jonathan Snipes, MD. She reviews patient-journey, clinical-workflow and care-model content: intake quality, prescriber review processes, follow-up access, refill workflows and support escalation. Her NPI record (1144661760) is listed in the CMS NPPES registry.
Credentials & verification
- Role
- Medical Reviewer (nurse practitioner)
- NPI
- 1144661760 — verified in the CMS National Plan & Provider Enumeration System registry
- Review scope
- Clinical workflow and patient-care review: provider reviews, care-model comparisons, support testing.
- Verification
- NPI record checked against the CMS NPPES registry.
Conflict disclosure
Kim Callender, NP, FNP-BC is not compensated based on any reviewed provider's sales. The publisher’s relationship with NexLife is described on our conflicts-of-interest page. See our conflicts-of-interest policy.
How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.